N-Acetylcysteine attenuated pulmonary fibrosis induced by bleomycin via immunomodulation responses
Background and purpose: Pulmonary fibrosis (PF) is a chronic and life-threatening interstitial lung disease. N-acetyl cysteine (NAC) is an antioxidant pharmaceutically available to reduce endothelial dysfunction, inflammation, and fibrosis, however, the therapeutic effect of NAC on PF has not been c...
Main Authors: | Zahra Maghsadi, Abbas Azadmehr, Ali Akbar Moghadamnia, Farideh Feizi, Negar Hamidi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Research in Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2023;volume=18;issue=2;spage=177;epage=184;aulast=Maghsadi |
Similar Items
-
Administration of Collagen Peptide Prevents the Progression of Pulmonary Fibrosis in Bleomycin-Treated Mice
by: Minami Yoshihara, et al.
Published: (2023-07-01) -
Immune Mechanisms of Pulmonary Fibrosis with Bleomycin
by: Yuko Ishida, et al.
Published: (2023-02-01) -
Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
by: Saber Mehdizadeh, et al.
Published: (2022-10-01) -
17,20S(OH)<sub>2</sub>pD Can Prevent the Development of Skin Fibrosis in the Bleomycin-Induced Scleroderma Mouse Model
by: Monica L. Brown Lobbins, et al.
Published: (2021-08-01) -
Saffron Protection against Bleomycin-Induced Pulmonary Fibrosis in Rats
by: Mehrzad Bahtouee, et al.
Published: (2017-11-01)